{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:40:04Z","timestamp":1791124804509,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1002\/jps.21807","type":"journal-article","created":{"date-parts":[[2009,6,4]],"date-time":"2009-06-04T15:45:43Z","timestamp":1244130343000},"page":"467-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Drug\u2013drug interaction between oxycodone and adjuvant analgesics in blood\u2013brain barrier transport and antinociceptive effect"],"prefix":"10.1016","volume":"99","author":[{"given":"Yusuke","family":"Nakazawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Okura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Deguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21807_bb0010","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.094276","article-title":"Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats","volume":"316","author":"Peckham","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21807_bb0015","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In vivo blood-brain barrier transport of oxycodone in the rat: Indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostr\u00f6m","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21807_bb0020","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1023\/A:1023250900462","article-title":"Morphine blood-brain barrier transport is influenced by probenecid co-administration","volume":"20","author":"Tunblad","year":"2003","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21807_bb0025","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21807_bb0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1634\/theoncologist.9-5-571","article-title":"Adjuvant analgesics in cancer pain management","volume":"9","author":"Lussier","year":"2004","journal-title":"Oncologist"},{"key":"10.1002\/jps.21807_bb0035","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/jps.21807_bb0040","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0090-9556(24)11822-3","article-title":"Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat","volume":"270","author":"Letrent","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1002\/jps.21807_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10611860008997912","article-title":"mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting","volume":"8","author":"Hosoya","year":"2000","journal-title":"J Drug Target"},{"key":"10.1002\/jps.21807_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2006.06.067","article-title":"Antinociceptive action of (+\/\u2212)-cis-(6-ethyl-tetrahydropyran-2-yl)formic acid in mice","volume":"550","author":"Marinho","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1002\/jps.21807_bb0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2116\/analsci.21.337","article-title":"Determination of oxycodone and hydrocotarnine in cancer patient serum by high-performance liquid chromatography with electrochemical detection","volume":"21","author":"Kokubun","year":"2005","journal-title":"Anal Sci"},{"key":"10.1002\/jps.21807_bb0060","doi-asserted-by":"crossref","first-page":"788","DOI":"10.5649\/jjphcs.32.788","article-title":"Pain assessment for cancer patients based on their pain descriptions (Part 2)\u2014Preliminary study for selecting adequate analgesics and adjuvant analgesics using APQ","volume":"32","author":"Inagaki","year":"2006","journal-title":"Jpn J Pharm Health Care Sci"},{"key":"10.1002\/jps.21807_bb0065","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1124\/jpet.102.036004","article-title":"Studies on functional sites of organic cation\/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein","volume":"302","author":"Ohashi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1002\/jps.21807_bb0070","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2165\/00003088-200241110-00004","article-title":"Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression","volume":"41","author":"Ulrich","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/jps.21807_bb0075","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/sj.bjp.0701882","article-title":"The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds","volume":"124","author":"Gray","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1002\/jps.21807_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jpsychires.2005.10.005","article-title":"Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls","volume":"41","author":"Uhr","year":"2007","journal-title":"Psychiatr Res"},{"key":"10.1002\/jps.21807_bb0085","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833","volume":"94","author":"Bostr\u00f6m","year":"2005","journal-title":"J Pharm Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916303720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354916303720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T22:35:24Z","timestamp":1739140524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354916303720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0022354916303720"],"URL":"https:\/\/doi.org\/10.1002\/jps.21807","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug\u2013drug interaction between oxycodone and adjuvant analgesics in blood\u2013brain barrier transport and antinociceptive effect","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/jps.21807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Wiley-Liss, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}